Cargando…
Treatment of atherosclerosis by macrophage-biomimetic nanoparticles via targeted pharmacotherapy and sequestration of proinflammatory cytokines
Vascular disease remains the leading cause of death and disability, the etiology of which often involves atherosclerosis. The current treatment of atherosclerosis by pharmacotherapy has limited therapeutic efficacy. Here we report a biomimetic drug delivery system derived from macrophage membrane co...
Autores principales: | Gao, Cheng, Huang, Qiaoxian, Liu, Conghui, Kwong, Cheryl H. T., Yue, Ludan, Wan, Jian-Bo, Lee, Simon M. Y., Wang, Ruibing |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7251120/ https://www.ncbi.nlm.nih.gov/pubmed/32457361 http://dx.doi.org/10.1038/s41467-020-16439-7 |
Ejemplares similares
-
Amelioration of ulcerative colitis via inflammatory regulation by macrophage-biomimetic nanomedicine
por: Sun, Tianlei, et al.
Publicado: (2020) -
Macrophage membrane functionalized biomimetic nanoparticles for targeted anti-atherosclerosis applications
por: Wang, Yi, et al.
Publicado: (2021) -
Pro-efferocytic macrophage membrane biomimetic nanoparticles for the synergistic treatment of atherosclerosis via competition effect
por: Sha, Xuan, et al.
Publicado: (2022) -
Metoprolol Reduces Proinflammatory Cytokines and Atherosclerosis in ApoE(−/−) Mice
por: Ulleryd, Marcus A., et al.
Publicado: (2014) -
The Role of miRNA-146a and Proinflammatory Cytokines in Carotid Atherosclerosis
por: Huang, Pan, et al.
Publicado: (2020)